Frontline Immunotherapy/Bevacizumab Ups PFS in PD-L1 –Positive mRCC

This video examines a phase II study that compared atezolizumab with or without bevacizumab vs sunitinib in untreated patients with metastatic renal cell carcinoma.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Tags: Videos Genitourinary Cancers Source Type: news